巴西公共卫生系统评估的缩乳术成本效益分析。
Cost-utility of reduction mammaplasty assessed for the Brazilian public health system.
作者信息
Araújo Carlos Delano Mundim, Veiga Daniela Francescato, Hochman Bernardo Sérgio, Abla Luiz Eduardo Felipe, Oliveira Ana Carolina Salles, Novo Neil Ferreira, Veiga-Filho Joel, Ferreira Lydia Masako
机构信息
Dr Araújo is a Preceptor in the Division of Orthopedics, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Veiga is an Associate Professor of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, Brazil, and is an Associate Professor in the Division of Plastic Surgery, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDrs Hochman and Abla are Associate Professors of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, BrazilDr Oliveira is a medical student at the School of Medicine, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Novo is a Full Professor in the Department of Biostatistics, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Veiga-Filho is an Associate Professor in the Division of Plastic Surgery, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Ferreira is a Full Professor of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, Brazil.
Dr Araújo is a Preceptor in the Division of Orthopedics, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Veiga is an Associate Professor of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, Brazil, and is an Associate Professor in the Division of Plastic Surgery, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDrs Hochman and Abla are Associate Professors of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, BrazilDr Oliveira is a medical student at the School of Medicine, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Novo is a Full Professor in the Department of Biostatistics, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Veiga-Filho is an Associate Professor in the Division of Plastic Surgery, Department of Surgery, University of Vale do Sapucaí, Pouso Alegre, BrazilDr Ferreira is a Full Professor of the Plastic Surgery Postgraduate Program, Federal University of São Paulo, São Paulo, Brazil
出版信息
Aesthet Surg J. 2014 Nov;34(8):1198-204. doi: 10.1177/1090820X14539972. Epub 2014 Jun 27.
BACKGROUND
Economic evaluation is important for making decisions about resource allocation. Few cost-utility or cost-effectiveness studies on breast hypertrophy have been reported in the medical literature.
OBJECTIVES
The authors sought to determine the cost-utility of reduction mammaplasty in the Brazilian national health care system.
METHODS
This randomized controlled study was conducted in a university-affiliated hospital. Sixty patients with breast hypertrophy were enrolled prospectively and were assigned randomly to either the control group (n = 30 patients who received follow-up for 6 months) or the treatment group (n = 30 patients who underwent reduction mammaplasty). Direct costs were recorded, and the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) was administered to both groups at the beginning of the study (preoperatively for the treatment group) and 3 and 6 months postoperatively. Utility was determined with Instrument 6D of the Brazilian version of the Short-Form Health Survey (SF-6D), from the SF-36 data.
RESULTS
At the 6-month follow-up, the treatment group showed an improvement in utility, with an average direct cost of approximately £104.
CONCLUSIONS
Reduction mammaplasty performed in the Brazilian national health care system provides a cost-utility ratio equivalent to approximately £142 per 1 quality-adjusted life year.
背景
经济评估对于资源分配决策很重要。医学文献中报道的关于乳房肥大的成本效用或成本效益研究很少。
目的
作者试图确定在巴西国家医疗保健系统中进行缩乳术的成本效用。
方法
这项随机对照研究在一家大学附属医院进行。前瞻性纳入60例乳房肥大患者，并随机分为对照组（n = 30例，接受6个月随访）或治疗组（n = 30例，接受缩乳术）。记录直接成本，并在研究开始时（治疗组术前）以及术后3个月和6个月对两组进行医学结局研究36项简表健康调查（SF - 36）。根据SF - 36数据，使用巴西版简表健康调查（SF - 6D）的6D工具确定效用。
结果
在6个月的随访中，治疗组的效用有所改善，平均直接成本约为104英镑。
结论
在巴西国家医疗保健系统中进行的缩乳术的成本效用比约为每1个质量调整生命年142英镑。
Zotero 插件